Kim Luu, Manager, Assay Development Team, IntelliCyt Inc
Abstract
Multiplexed technologies are increasingly being incorporated into discovery programs evaluating the efficacy and toxicity of compounds. We will discuss a novel system for performing multiplex phenotypic screening assays on suspensions of cell or beads.